Novo Nordisk Just Committed More Than $1.1 Billion to Make the Next Ozempic, but Is the Stock a Buy?
In mid-September, Novo Nordisk inked a pair of deals worth a total of more than $1.1 billion in research and development (R&D ...
Senators press Novo Nordisk CEO on why Ozempic and Wegovy cost less abroad
Weight-loss drugs sell in Europe for a fraction of what they cost in the United States, a pattern that is typical for ...
Novo Nordisk’s Wegovy-Fueled Gains Fading as Analyst Doubts Grow
The obesity-drug hype that fueled huge gains in Novo Nordisk A/S looks to be running out of steam. Novo shares fell as much as 4.6% to a seven-month low on Friday after a JPMorgan Chase & Co. analyst ...
Novo Nordisk's $600 Million Gambit Could Be a Game Changer for the Stock. Here's Why.
The healthcare company's pivot into a new set of technologies will have many implications for the stock.
Evotec and Novo Nordisk in technology development partnership
(Reuters) -German drug and development company Evotec has entered into a technology development partnership with Novo Nordisk ...
FiercePharma4d
Novo Nordisk scolded by UK drug marketing watchdog over sponsorship of weight loss services
Novo Nordisk has earnt yet another dressing down from the PMCPA. The U.K. | Novo Nordisk has earnt yet another dressing down ...
Investing16h
Novo Nordisk A/S Class B (NOVOb)
Novo Nordisk (CO:NOVOb) (NVO -1.9%) submits a type 2 variation application to the European Medicines Agency (EMA) seeking approval to add data from two late-stage studies... LONDON (Reuters ...
RFK Jr. bashes Ozempic buzz and Novo Nordisk profits
Robert F. Kennedy Jr. criticized Ozempic and Danish pharmaceutical company Novo Nordisk, arguing that fixing the food supply ...